Skip to Main Content

Author Details

Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
2017
20
11
PMIDPaper TitleJournal TitlePublished Year
36206500Pancreatic Adenocarcinoma: An Evolving Yet Unimpressive Treatment Landscape.JCO Oncol Pract2023
37210048A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.Int J Radiat Oncol Biol Phys2023
37232840Fiducial Markers Allow Accurate and Reproducible Delivery of Liver Stereotactic Body Radiation Therapy.Curr Oncol2023
34862244Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma.Clin Cancer Res2022
36468417The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance.Immunotherapy2022
33119176Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.Cancer2021
33883256Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.J Immunother Cancer2021
33846085Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer.Urol Oncol2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
33277184Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer.HPB (Oxford)2021
33097963Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.Cancer Immunol Immunother2021
32567728The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.Mol Carcinog2020
32363633The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.Mol Carcinog2020
30846177Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.Oral Oncol2019
31422804SBRT for Early Stage Larynx: A Go or No Go? It's All in the Delivery.Int J Radiat Oncol Biol Phys2019
31042320Imaging at diagnosis impacts cancer-specific survival among patients with cancer of the oropharynx.Cancer2019
30894369Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.Cancer Res2019
30863843STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.J Natl Cancer Inst2019
30944125Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.Clin Cancer Res2019
27203149BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases.J Neurosurg2017
  • 1 - 20 of 20

Recommended Authors

Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Stanford University
Career Start Year 2014
Number of shared co-authors 0
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 0
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 0
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 1
Emory University
Career Start Year 2011
Number of shared co-authors 0
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 0
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 0
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 0
University of California los angeles
Career Start Year 2007
Number of shared co-authors 0
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 2
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 0
University of California san francisco
Career Start Year 1999
Number of shared co-authors 1
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 1
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 0
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 1

Collaborators

University of Colorado School of Medicine
Co-authored papers 13
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 8
University of Colorado
Co-authored papers 8
Universite de Sherbrooke
Co-authored papers 7
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 7
University of Colorado Anschutz Medical Campus
Co-authored papers 6
Mount Sinai Hospital
Co-authored papers 6
University of Colorado School of Medicine
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of Colorado
Co-authored papers 4
University of Colorado Anschutz Medical Campus
Co-authored papers 3
University of Washington
Co-authored papers 3
University of Colorado Denver
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers 2
University of Colorado Denver | Anschutz Medical Campus
Co-authored papers 2
University of Colorado
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
University of Colorado
Co-authored papers 2
Ruijin Hospital
Co-authored papers 1
University of Colorado
Co-authored papers 1
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
University of Colorado School of Medicine
Co-authored papers 1
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Cardiovascular Institute, University of Colorado Denver Anschutz Medical Campus
Co-authored papers 1
University of Colorado
Co-authored papers 1